Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNY3 pseudogene 11 is a processed non-coding RNA pseudogene on human chromosome 6 (chr6:109305494-109305595) with high sequence similarity to the functional RNY3 gene, which is part of the Y RNA family[5]. Like other Y RNA family pseudogenes, RNY3P11 arises from reverse transposition events and does not produce functional proteins[1][5][2]. Y RNA pseudogenes are widely distributed in the human genome, with over 1,000 copies described[2]. The functional Y RNAs (most notably RNY3) play roles in the assembly of ribonucleoprotein complexes (such as Ro60), the regulation of non-coding RNA quality, and, potentially, DNA replication and immune responses[1][2]. Although some Y RNA pseudogenes may be transcribed in certain contexts, there is no evidence for a direct biological function, disease role, drug interaction, or biomarker use for RNY3 pseudogene 11 itself[1][5]. The gene is not recognized as a druggable target or as part of any well-defined molecular family relevant to therapeutic intervention[5][3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNY3 pseudogene 11 (RNY3P11).